Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflurane versus propofol + remifentanil for elective laparoscopic cholecystectomy
IRCT20260412069062N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cholelithiasis comparing Isoflurane with Propofol + Remifentanil (2 arms). Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 5 more. Started May 2026; status: completed.
02
Drugs
isofluranepropofolremifentanil
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on IRCT20260412069062N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260412069062N1.